Females may require lower doses than males to achieve the desired effects
Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
Accessed 13 May 2013
Meditation, grounding, visualization, JFB Myofascial Release, Yoga and Tai Chi are other techniques to support parasympathetic dominance and optimize stress resilience
SHRSP-Tg(Gstm1)1WKY 0.024 0.002mmol/l and SHRSPTg(Gstm1)2WKY 0.021 0.002mmol/l
Due to its cyclic structure, MT-2 exhibits significantly enhanced metabolic stability and an extended biological half-life of approximately 33 to 36 hours compared to linear -MSH